(Q36947722)

17 August 2017

1 reference

title

Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions (English)

1 reference

17 August 2017

0 references

2

Angelo Ghezzi

1 reference

17 August 2017

3

Amit Bar-Or

1 reference

17 August 2017

Brenda Banwell

1

1 reference

17 August 2017

Yann Mikaeloff

series ordinal

4

1 reference

17 August 2017

Marc Tardieu

series ordinal

5

1 reference

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

10

1 reference

17 August 2017

887-902

1 reference

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Brain abnormalities in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuromyelitis optica: clinical predictors of a relapsing course and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Risk factors for developing multiple sclerosis after childhood optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Proposed diagnostic criteria and nosology of acute transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Toward the definition of acute disseminated encephalitis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

The clinical features, MRI findings, and outcome of optic neuritis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Recovery after optic neuritis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Optic neuritis in children: recurrence and subsequent development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute transverse myelitis in childhood: nine cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Efficacy of high dose steroid therapy in children with severe acute transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute transverse myelopathy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Rapid recovery from transverse myelopathy in children treated with methylprednisolone.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

High dose methylprednisolone in severe acute transverse myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Rapid onset transverse myelitis in adolescence: implications for pathogenesis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute transverse myelitis in children: clinical course and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute flaccid paralysis in Australian children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Transverse myelitis in children: long-term urological outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Determinants of prognosis of acute transverse myelitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

MRI findings in acute idiopathic transverse myelopathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute transverse myelitis in childhood: center-based analysis of 47 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuromyelitis optica in childhood: case report with sequential MRI findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuromyelitis optica (Devic syndrome) in a 12-year-old male with complete recovery following steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neurocognitive outcome after acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Magnetic resonance imaging, evoked responses and cerebrospinal fluid findings in a follow-up study of children with optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Quantifying axonal loss after optic neuritis with optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Optical coherence tomography in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Differential diagnosis and evaluation in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuroimaging in pediatric leukemia and lymphoma: differential diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Primary central nervous system vasculitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Central nervous system vasculitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood primary angiitis of the central nervous system: two biopsy-proven cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

CNS disease as the main manifestation of hemophagocytic lymphohistiocytosis in two children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

What is acute disseminated encephalomyelitis (ADEM)?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Magnetic resonance in childhood white-matter disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Genetic disorders that masquerade as multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Prognostic factors for early severity in a childhood multiple sclerosis cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

CSF characteristics in early-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Cerebrospinal fluid findings in Devic's neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Early onset MS under the age of 16: clinical and paraclinical features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Prospective study of multiple sclerosis with early onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in children under 6 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Neuromyelitis optica immunoglobulin G in a child

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood multiple sclerosis (MS): multimodal evoked potentials (EP) and magnetic resonance imaging (MRI) comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Immunopathogenesis of multiple sclerosis: MBP and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in adolescents: CT and MR findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

A Preliminary Diffusion Tensor and Magnetization Transfer Magnetic Resonance Imaging Study of Early-Onset Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Myelin in multiple sclerosis is developmentally immature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Early onset multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in childhood: clinical profile in 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Course and prognosis in early-onset MS: comparison with adult-onset forms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in childhood: clinical features of 149 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in children: report of clinical and paraclinical features of 19 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

A long perspective on childhood multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Clinical characteristics and long term prognosis in early onset multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Pediatric multiple sclerosis report of 14 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Primary CNS demyelinating diseases in childhood: multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in childhood: contribution of serial MRI to earlier diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Juvenile multiple sclerosis: clinical features and prognostic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in children under 10 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in childhood: report of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis with childhood onset: report of 21 cases in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple Sclerosis in Black Children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Epidemiology of multiple sclerosis: a critical overview.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

The cognitive burden of multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Cognitive functioning in children and adolescents with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

1 reference

7 January 2021

Onset of multiple sclerosis in a 24-month-old child

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Very early onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis with early childhood onset. A case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Natural history of multiple sclerosis with childhood onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Pituitary adrenal recovery following short-term suppression with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Treatment of Early Onset Multiple Sclerosis with Suboptimal Dose of Interferon Beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interferon-beta treatment in patients with childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interferon beta-1a in children with multiple sclerosis is well tolerated

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

The use of interferon beta in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Why treat early multiple sclerosis patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Genetics of multiple sclerosis [published erratum appears in Hum Mol Genet 1997 Nov;6(12):2189]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Association and linkage of juvenile MS with HLA-DR2(15) in Russians

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Tumor necrosis factor-alpha gene polymorphisms in children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Myelin oligodendrocyte gene polymorphisms and childhood multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis and antecedent infections: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Epstein-Barr virus in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood infections and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Childhood multiple sclerosis: Clinical features and demonstration of changes in T cell subsets with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Leber's hereditary optic neuropathy mitochondrial DNA mutations in childhood multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Characterization of the mitochondrial genome in childhood multiple sclerosis. II. Multiple sclerosis without optic neuritis and LHON-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Characterization of the mitochondrial genome in childhood multiple sclerosis. III. Multiple sclerosis without optic neuritis and the non-LHON-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970242-9

7 January 2021

10.1016/S1474-4422(07)70242-9

Identifiers

DOI

1 reference

17 August 2017

1 reference